Kendric Cromer, 12, became the first patient to undergo a new commercially approved gene therapy treatment for sickle cell disease at Children's National Hospital in Washington, D.C. last week.
The post Black 12-Year-Old Patient Begins New Sickle Cell Therapy Treatment appeared first on Black America Web.
